Tazemetostat
Tazemetostat (EPZ6438) is a potent, selective, and orally bioavailable SAM-competitive inhibitor of the EZH2 histone methyltransferase (IC50=11 nM) . It demonstrates antitumor efficacy in preclinical models and is used in research for cancers like epithelioid sarcoma and follicular lymphoma, supporting both in vitro and in vivo experimental studies.
Product Specifications
CAS Number
1403254-99-8
Product Name Alternative
EPZ-6438
Field of Research
Cancer Biology, Epigenetics & Chromatin, Stem Cell & Developmental Biology
Purity
>98%
Bioactivity
EZH2 inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to at least 25 mg/ml)
Smiles
CCN (C1CCOCC1) c1cc (cc (C (=O) NCc2c (C) cc (C) [nH]c2=O) c1C) -c1ccc (CN2CCOCC2) cc1
Molecular Formula
C34H44N4O4
Molecular Weight
572.8
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N-[ (1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl) methyl]-5-[ethyl (tetrahydro-2H-pyran-4-yl) amino]-4-methyl-4'- (4-morpholinylmethyl) -[1,1'-biphenyl]-3-carboxamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog